Semantic Scholar uses AI to extract papers important to this topic.
To compare the efficacy and safety of adalimumab plus methotrexate (MTX) versus MTX monotherapy or adalimumab… Expand BACKGROUND
Quinquennial overviews (1985-2000) of the randomised trials in early breast cancer have assessed the 5 year and 10… Expand OBJECTIVE
To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti-tumor necrosis factor… Expand BACKGROUND
Methotrexate is the most frequent choice of disease-modifying antirheumatic therapy for rheumatoid arthritis. Although… Expand BACKGROUND
Etanercept, which blocks the action of tumor necrosis factor, reduces disease activity in patients with long-standing… Expand BACKGROUND
Neutralization of tumor necrosis factor a (TNF-alpha) for three to six months reduces the symptoms and signs of… Expand BACKGROUND
Patients treated with methotrexate for rheumatoid arthritis often improve but continue to have active disease. This… Expand Methotrexate (MTX) has become an important drug in the treatment of rheumatoid arthritis (RA). The American College of… Expand Twenty-eight patients with refractory rheumatoid arthritis completed a randomized 24-week double-blind crossover trial comparing… Expand METHOTREXATE, the most widely used antimetabolite in cancer chemotherapy, has an essential role in the treatment of such diverse… Expand